mRNA Vaccine + Keytruda Shows Promise in Preventing Melanoma Recurrence
Personalized mRNA Vaccine Shows Promise in Melanoma Recurrence Prevention A groundbreaking mRNA-based cancer vaccine, developed in tandem with the immunotherapy drug Keytruda, has demonstrated a 52% reduction in melanoma recurrence ... Read More